<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03484949</url>
  </required_header>
  <id_info>
    <org_study_id>xjtu-20170816</org_study_id>
    <nct_id>NCT03484949</nct_id>
  </id_info>
  <brief_title>Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer</brief_title>
  <official_title>Randomized Trial Comparing Gastroscopy Following Web-Mediated Risk Assessment With Routine Endoscopy for Gastric Cancer Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State Key Laboratory of Cancer Biology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>State Key Laboratory of Cancer Biology</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastric cancer is one of the most common malignancies in China. Early detection is critical
      for gastric cancer management. However, the diagnosis rate of patients with early gastric
      cancer is still low. Therefore, the investigator design this study to access whether
      pre-endoscopic screening risk assessment of genetic and environmental risk factors could
      improve early gastric cancer diagnosis rate.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic rate of patients with early gastric cancer</measure>
    <time_frame>2020</time_frame>
    <description>Diagnostic rate of patients with early gastric cancer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterization of the high-rik individual for gastric cancer</measure>
    <time_frame>2020</time_frame>
    <description>Diagnostic rate of patients with early gastric cancer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>pre-endoscopic screening risk assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>routine screening</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>pre-endoscopic screening risk assessment</intervention_name>
    <description>pre-endoscopic screening risk assessment</description>
    <arm_group_label>pre-endoscopic screening risk assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1.Age 18-60. 2.Signed informed consent

        Exclusion Criteria:

          -  1.Severe back ground disease including malignancy. 2.State after gastric surgery.
             3.COPD, CHF, CRF and any disease with respiratory disturbances. 4.Deviation of the
             nasal septum, lack of venous access at the dorsum of the hand or any other technical
             problem prevents gastric acid collection or base excess evaluation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dake Chu, M.D.</last_name>
    <phone>86-29-85323922</phone>
    <email>chudake@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dake Chu</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dake Chu, M.D.</last_name>
      <email>chudake@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2018</study_first_submitted>
  <study_first_submitted_qc>March 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2018</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Health Science Center of Xiâ€™an Jiaotong University</investigator_affiliation>
    <investigator_full_name>Dake Chu</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Gastric cancer</keyword>
  <keyword>Screening</keyword>
  <keyword>Risk assessment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

